← SynDRA
PRX-08066 FREE BASE
SynDRA canonical compound SYN0012005 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | HTR2B |
|---|
| Mechanism of action | Serotonin receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- Serotonin receptor antagonist
- HTR2B ANTAGONIST
- Serotonin 2b (5-HT2b) receptor antagonist
Cross-references
Synonyms
- PRX-08066
- RefChem:913055
- UNII-82SK298EBU
- C19H17ClFN5S
- orb1307842
- SCHEMBL1604039
- SCHEMBL29390783
- SCHEMBL31237398
- IENZFHBNCRQMNP-UHFFFAOYSA-N
- HMS3748I19
- BDBM50249180
- MFCD20488005
- ZB1197
- AKOS030526950
- CS-0991
- PRX-08066?
- SB16508
- NCGC00386238-02
- FP102683
- HY-15472
- MS-26846
- NS00072445
- C76824
- T16669
- BRD-K16757695-050-02-5
- 82SK298EBU
- PRX 08066
- QC-5875
- PRX08066
- PRX 08066;PRX08066
- CHEMBL513994
- 5-((4-(6-Chlorothieno(2,3-d)pyrimidine-4-ylamino)piperidin-1-yl)methyl)-2-fluorobenzonitrile
- Benzonitrile, 5-((4-((6-chlorothieno(2,3-d)pyrimidi
- BCP14768
- DTXSID60235710
- Prx-08066
- AK548029
- 5-((4-(6-chlorothieno[2,3-d]pyrimidin-4-ylamino)piperidin-1-yl)methyl)-2-fluorobenzonitrile
Look up PRX-08066 FREE BASE in the interactive SynDRA portal →